The French National Institute for Health and Medical Research (Inserm) is committed to making its service accessible, in accordance with article 47 of law no. 2005-102 of February 11, 2005.
This declaration of accessibility applies to the website of the Priority Research Program and Equipment (PEPR) Biotherapy and Bioproduction of Innovative Therapies.
The Priority Research Program and Equipment (PEPR) Biotherapy and Bioproduction of Innovative Therapies website is not compliant with RGAA 4.1. The site has not yet been audited.
This declaration has been established on January 22, 2024.
If you are unable to access a content or service, you can contact the Priority Research Program and Equipment (PEPR) Biotherapy and Bioproduction of Innovative Therapies site manager to be directed to an accessible alternative or obtain the content in another form.
Contact email: programmes.strategiques@inserm.fr
Address: 101 rue de Tolbiac, 75654 Paris cedex 13, France
This procedure is to be used in the following case: you have notified the website manager of an accessibility fault that is preventing you from accessing content or one of the portal’s services, and you have not received a satisfactory response.
You can:
Write a message to the Rights Defender
Contact the Rights Defender (Défenseur des droits) delegate in your region
Send a letter by post (free of charge, do not use a stamp):
Rights Defender (Défenseur des droits)
Libre réponse 71120 75342 Paris CEDEX 07
This accessibility declaration was created on January 22, 2024 using BetaGouv’s Accessibility Declaration Generator.